Earnings Labs

Octave Specialty Group, Inc. (OSG)

Q2 2019 Earnings Call· Fri, Aug 9, 2019

$4.60

+1.43%

Key Takeaways · AI generated
AI summary not yet generated for this transcript. Generation in progress for older transcripts; check back soon, or browse the full transcript below.

Same-Day

+0.00%

1 Week

+1.19%

1 Month

+6.33%

vs S&P

+3.37%

Transcript

Operator

Operator

Greetings and welcome to the Ambac Financial Group, Inc's Second Quarter 2019 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your hosts, Lisa Kampf, Head of Investor Relations; Claude LeBlanc, Chief Executive Officer; and David Trick, Chief Financial Officer. I will now turn the call over to Lisa.

Lisa Kampf

Analyst

Thank you. Good morning and thank you all for joining today’s conference call to discuss Ambac Financial Group’s second quarter 2019 financial results. We would like to remind you that today’s presentation may contain forward-looking statements, which are based on management’s current expectations and are subject to uncertainty and changes in circumstances. Any forward-looking statements are not guarantees of future performance of events. Actual performance and events may differ possibly materially from such forward-looking statements. Factors that could cause this include the factors described in our most recent SEC filed quarterly or annual report under Management’s Discussion & Analysis of Financial Condition and Results of Operations and under Risk Factors. Ambac is not under any obligation and expressly disclaims any obligation to update any forward-looking statement whether as a result of new information, future events or otherwise. Today’s presentation contains non-GAAP financial measures. The reconciliations of such measures to the most comparable GAAP figures are included in our earnings press release which is available on our website at ambac.com. Please note that presentations have been posted to the Events & Presentations section of our IR website, which supports our comments today. I would now like to turn the call over to Mr. Claude LeBlanc.

Claude LeBlanc

Analyst

Thank you, Lisa and welcome to everyone joining today’s call. During the second quarter, we continued to make significant progress on our key strategic priorities, including the active de-risking of our insured portfolio further reducing our insured net par by approximately $2.3 billion to $42.2 billion with $1.6 billion of the decline representing adversely classified and watch list credits. This represents a further 5.1% decline in our overall insured portfolio for the quarter and 10.1% year-to-date following the 25% reduction achieved in 2018. More importantly, adversely classified and watch list credits declined by 8.3% during the quarter representing a large component of the overall portfolio decline. The reduction in net par outstanding for the second quarter of 2019 was driven by several key de-risking transactions, including the Ballantyne restructuring and commutation which closed on June 18. The successful execution of the Ballantyne restructuring, one of the largest credit exposures of Ambac UK reduced our adversely classified credit exposure by $900 million and dramatically improved Ambac UK’s regulatory capital position to near required levels. We continue to actively explore various options to sculp and de-risk our insured portfolio and reduce potential tail risks, which may include large scale commutations, remediations or reinsurance transactions that could, in certain scenarios negatively impact our book value and/or adjusted book value that we believe will improve the overall quality of our book value as well as accelerate the timing and options to distribute capital from our insurance subsidiaries. For the quarter ended June 30, 2019, Ambac reported a net loss of $128 million or $2.79 per diluted share and a decrease in book value per share of $2.85 to $32.78 from March 31, 2019. Adjusted earnings were $86 million or $1.88 per diluted share for the second quarter of 2019 resulting in an increased in…

David Trick

Analyst

Thank you, Claude and good morning to everyone. During the second quarter of 2019, Ambac incurred a net loss of $128 million or $2.79 per diluted share compared to a net loss of $43.2 million or $0.94 per diluted share in the first quarter of 2019. As Claude discussed the main driver of second quarter results was the execution of the Ballantyne restructuring and commutation, which resulted in a GAAP net loss of $83 million. The loss was a result of accelerated amortization of the insurance intangible assets. In addition to the impact of Ballantyne, second quarter results were impacted by net positive development from loss and loss expenses at a higher net loss on derivative contracts compared to the first quarter of 2019. Adjusted earnings for the second quarter were $86 million or $1.88 per diluted share compared to an adjusted loss of $9 million or $0.20 per diluted share in the first quarter. Adjusted earnings were driven by $119 million gain from the Ballantyne commutation, the primary difference between the adjusted earnings from GAAP earnings being the exclusion of the insurance intangible assets amortization expense. Notable items the second quarter include premiums earned of $8 million versus $28 million during the first quarter, while normal earned premium only decreased by about $2 million to $14 million due to the continued reduction of the insured portfolio. Accelerated premiums declined $18 billion from the first quarter. The swing in the accelerated premium was mostly a result of $6 million of negative accelerated premiums realized in the second quarter driven by the Ballantyne commutation compared to $12 million positive accelerated premium realized in the first quarter mostly related to the COFINA transaction. Investment income for the second quarter was $86 million, a $32 million increase from $55 million for the first…

Claude LeBlanc

Analyst

Thank you, David. We are proud of our achievements for the second quarter. Our progress this reflects our ongoing commitment to execute on strategies that we believe will deliver long-term value to our shareholders. Thank you again for joining us today. I will now turn the call back to the operator and open the line for questions.

Operator

Operator

Thank you. [Operator Instructions] Our first question comes from the line of Giuliano Bologna with BTIG. Please proceed with your question.

Giuliano Bologna

Analyst

Good morning.

Claude LeBlanc

Analyst

Good morning.

Giuliano Bologna

Analyst

Just trying to think about the CDO proceeds another year of approval for the [indiscernible] about $142 million in the third quarter, do you have any goals related to the deployment of that capital, would you deploy it for a loss mitigation or essentially to buy down some of your outstanding debt?

Claude LeBlanc

Analyst

Hi, good morning Giuliano. That’s a good question. It’s something we are still evaluating from a capital allocation perspective, but we have a couple of different uses that we are evaluating and expect to make a decision in the near-term [indiscernible] for you this morning.

Giuliano Bologna

Analyst

That makes sense. Then I guess following up on a similar question, now that you also have Ballantyne transaction done, are there any opportunities for other new business or capital leases from Ambac UK?

Claude LeBlanc

Analyst

Yes, Giuliano, so we are getting closer on the Solvency II capital position as we disclose that the whole Solvency II standpoint down to about 133 million pounds, it’s about a 130 million pound improvement over first quarter. So we expect that will continue to improve over next few quarters and hope to reach Solvency II threshold in the next couple of years. We will have to have discussions with the PRA much of course of what happens in the UK, particularly from a capital release standpoint is subject to regulatory approval. We will have to have discussions and engage with them about path forward from there in terms of capital releases, but nonetheless we are optimistic that we will be in a position to meet our solvency requirements in the next couple of years and as de-risk the book and continue to produce positive earnings there in the UK will get there sooner rather than later.

David Trick

Analyst

On the new business front again that’s in the UK it is something that we are evaluating in terms of have use very talented staff in the UK relatively small scale a process of [indiscernible] will considering opportunities for things that they can do primarily in a capital light type of business approach. We will have more to talk about that in the future if that’s appropriate.

Giuliano Bologna

Analyst

That sounds very good. Only one follow-up really to the comments you made about some of the expense savings, obviously at the RMBS platform than the personnel that you brought up, are there any one-time cost associated with completing those cost savings initiatives?

Claude LeBlanc

Analyst

There is and will be some severance expenses. We did have some additional severance expenses at the margin in the second quarter, the potentially additional marginal severance expenses in future periods, but nothing is material.

Giuliano Bologna

Analyst

That’s great. Thank you for taking my questions.

Claude LeBlanc

Analyst

Sure. Thank you.

Operator

Operator

Thank you. [Operator Instructions] Ladies and gentlemen, there are no further questions at this time. This concludes today’s conference. We thank you for your participation. You may now disconnect your lines. Thank you once again.